Benefits
Bioactive Coenzyme Form
P-5-P is the coenzyme form of B6. Swallowed P-5-P is dephosphorylated in the gut to pyridoxal before it is absorbed, so it does not bypass the body's phosphorylation steps the way it is marketed to. Healthy adults convert pyridoxine HCl efficiently, and no human trial shows P-5-P works better for them. A theoretical edge for people with impaired phosphorylation (some liver disease or genetic variants) has not been demonstrated in trials.
Neurotransmitter Synthesis
B6 (as PLP) is cofactor for amino acid decarboxylases that synthesize: serotonin (from 5-HTP), dopamine (from L-DOPA), GABA (from glutamate), histamine (from histidine), epinephrine, and norepinephrine. This is biochemistry: it explains why severe B6 deficiency impairs these pathways, but it is not evidence that B6 supplements improve mood in people who are not deficient, and no standalone depression or mood trial of B6 is cited here.
Premenstrual Syndrome (PMS)
Vitamin B6 supplementation (50-100 mg/day) modestly improves PMS symptoms — systematic review showed benefit; ACOG mentions B6 as option for PMS. P-5-P or pyridoxine HCl both used.
Morning Sickness / Nausea of Pregnancy
Vitamin B6 (10-25 mg three times daily) is first-line pharmacologic treatment for nausea and vomiting of pregnancy per ACOG. Often combined with doxylamine (Diclegis® / Diclectin®) for synergistic effect. Pyridoxine HCl is the studied form; P-5-P comparable.
Homocysteine Lowering
B6 (PLP) is a cofactor for cystathionine beta-synthase, which converts homocysteine to cystathionine. Adequate B6, folate, and B12 keep homocysteine levels lower. Important caveat: large randomized trials that lowered homocysteine with B vitamins (for example HOPE-2 and VISP) did not reduce heart attacks or strokes, so lowering this blood marker has not translated into fewer cardiovascular events.
Mechanism of action
Coenzyme for >140 Enzymes
PLP is cofactor for: amino acid transaminases (ALT, AST — clinical liver enzymes), amino acid decarboxylases (neurotransmitter synthesis), glycogen phosphorylase (glycogen breakdown), heme synthesis (delta-ALA synthase), cystathionine beta-synthase (homocysteine metabolism), kynureninase (tryptophan catabolism).
Phosphorylation Bypass
Pyridoxine HCl → pyridoxal → P-5-P requires liver pyridoxine kinase. P-5-P is already phosphorylated — directly usable. Practical advantage modest for healthy adults; may matter in liver disease, alcohol abuse, certain enzyme variants.
Neurotransmitter Decarboxylase Cofactor
Critical for: 5-HTP → serotonin; L-DOPA → dopamine; glutamate → GABA; histidine → histamine. B6 deficiency impairs all these pathways simultaneously.
Heme Synthesis
PLP is cofactor for delta-aminolevulinic acid synthase — first and rate-limiting step of heme biosynthesis. B6 deficiency causes sideroblastic anemia.
Clinical trials
Randomized crossover trial of pyridoxine (vitamin B6) for premenstrual syndrome (Doll 1989), consistent with a later systematic overview that lists B6 among options with modest supporting evidence.
Women with premenstrual syndrome in a randomized crossover trial.
B6 (50-100 mg/day) modestly improved PMS symptoms vs placebo. Effect size modest. ACOG recognizes as treatment option. Higher doses (>200 mg) carry neuropathy risk without proportional benefit.
Randomized, double-blind, placebo-controlled trial of pyridoxine for nausea and vomiting of pregnancy (Vutyavanich 1995); pyridoxine is an ACOG-recommended first-line treatment for these symptoms.
Pregnant women with NVP.
Pyridoxine effectively reduces NVP vs placebo. Combined with doxylamine (Diclegis®) for additive effect. Safe in pregnancy at recommended doses.